Literature DB >> 4115569

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia.

J F Bridgman, S M Rosen, J M Thorp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4115569     DOI: 10.1016/s0140-6736(72)91905-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  Clofibrate-induced myopathy in the rat.

Authors:  H Teräväinen; A Larsen; M Hillbom
Journal:  Acta Neuropathol       Date:  1977-08-16       Impact factor: 17.088

3.  Pharmacokinetics of drugs in patients with the nephrotic syndrome.

Authors:  R Gugler; D W Shoeman; D H Huffman; J B Cohlmia; D L Azarnoff
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

Review 4.  Reductase inhibitor therapy of hypercholesterolemia.

Authors:  R A Kreisberg
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

Review 5.  Diseases and drug protein binding.

Authors:  J P Tillement; F Lhoste; J F Giudicelli
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

6.  Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.

Authors:  H S Paul; S A Adibi
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

Review 7.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

Review 8.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

9.  Binding of four sulphonamides to human albumin.

Authors:  R Zini; P d'Athis; A Hoareau; J P Tillement
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

Review 10.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.